<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Anti-Xa | Clinical Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Anti-Xa Assays  Definition: Anti-Xa assays are laboratory tests used to measure the activity of anticoagulant drugs that inhibit Factor Xa (FXa), a key enzyme in the coagulation...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Anti-Xa | Clinical Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Anti-Xa Assays  Definition: Anti-Xa assays are laboratory tests used to measure the activity of anticoagulant drugs that inhibit Factor Xa (FXa), a key enzyme in the coagulation...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Anti-Xa | Clinical Hematology">
<meta name="twitter:description" content="Overview of Anti-Xa Assays  Definition: Anti-Xa assays are laboratory tests used to measure the activity of anticoagulant drugs that inhibit Factor Xa (FXa), a key enzyme in the coagulation...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><!-- Google tag (gtag.js) --><script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Clinical Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="active" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="anti-xa" class="section level1 unnumbered">
<h1>Anti-Xa<a class="anchor" aria-label="anchor" href="#anti-xa"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-anti-xa-assays" class="section level2 unnumbered">
<h2>
<strong>Overview of Anti-Xa Assays</strong><a class="anchor" aria-label="anchor" href="#overview-of-anti-xa-assays"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> Anti-Xa assays are laboratory tests used to measure the activity of anticoagulant drugs that inhibit Factor Xa (FXa), a key enzyme in the coagulation cascade</li>
<li>
<strong>Purpose:</strong>
<ul>
<li>Monitoring Low-Molecular-Weight Heparin (LMWH) Therapy: Used to monitor LMWH therapy, especially in patients with:
<ul>
<li>Renal insufficiency</li>
<li>Obesity</li>
<li>Pregnancy</li>
<li>Children</li>
<li>Other conditions where standard dosing may not be reliable</li>
</ul>
</li>
<li>Monitoring Unfractionated Heparin (UFH) Therapy: May be used as an alternative to the aPTT in certain situations</li>
<li>Monitoring Direct Oral Anticoagulants (DOACs): Used to measure the plasma concentration of direct oral anticoagulants (DOACs) that inhibit Factor Xa (e.g., rivaroxaban, apixaban, edoxaban) in specific situations</li>
<li>Assessing Heparin Contamination: Used to detect heparin contamination in blood samples from indwelling catheters</li>
</ul>
</li>
<li>
<strong>Principle:</strong> Anti-Xa assays measure the ability of an anticoagulant drug to inhibit Factor Xa activity in a plasma sample</li>
</ul>
</div>
<div id="key-concepts-anticoagulant-mechanisms-of-action" class="section level2 unnumbered">
<h2>
<strong>Key Concepts: Anticoagulant Mechanisms of Action</strong><a class="anchor" aria-label="anchor" href="#key-concepts-anticoagulant-mechanisms-of-action"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Heparin (UFH and LMWH):</strong>
<ul>
<li>Mechanism: Enhances the activity of antithrombin, a natural anticoagulant</li>
<li>Antithrombin inhibits several coagulation factors, including Factors IIa (thrombin), IXa, and Xa</li>
<li>LMWHs have a greater effect on Factor Xa inhibition compared to UFH</li>
</ul>
</li>
<li>
<strong>Fondaparinux:</strong>
<ul>
<li>A synthetic pentasaccharide that selectively inhibits Factor Xa via antithrombin</li>
</ul>
</li>
<li>
<strong>Direct Oral Anticoagulants (DOACs):</strong>
<ul>
<li>Direct Thrombin Inhibitors (DTIs): Inhibit thrombin (Factor IIa) directly (e.g., dabigatran)</li>
<li>Factor Xa Inhibitors: Inhibit Factor Xa directly (e.g., rivaroxaban, apixaban, edoxaban)</li>
</ul>
</li>
</ul>
</div>
<div id="components-of-the-anti-xa-assay-system" class="section level2 unnumbered">
<h2>
<strong>Components of the Anti-Xa Assay System</strong><a class="anchor" aria-label="anchor" href="#components-of-the-anti-xa-assay-system"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Instrumentation:</strong>
<ul>
<li>Automated Coagulation Analyzer: Capable of performing chromogenic or clot-based assays</li>
<li>Spectrophotometer: Used to measure the absorbance of the colored product in chromogenic assays</li>
</ul>
</li>
<li>
<strong>Reagents:</strong>
<ul>
<li>Antithrombin: Purified antithrombin reagent</li>
<li>Factor Xa: Purified Factor Xa reagent</li>
<li>Chromogenic Substrate: A synthetic peptide substrate that is cleaved by Factor Xa, releasing a colored product</li>
<li>Buffer: Tris buffer or other suitable buffer to maintain a stable pH</li>
<li>Calibrators: Standards with known concentrations of the anticoagulant drug</li>
<li>Control Materials: To perform instrument calibration</li>
</ul>
</li>
<li>
<strong>Sample Preparation:</strong>
<ul>
<li>Plasma: To isolate the plasma, the sample must be centrifuged</li>
<li>Specific anticoagulant is required for collection; test specifications should dictate if collection can use heparin or citrate</li>
</ul>
</li>
</ul>
</div>
<div id="procedure-for-performing-an-anti-xa-assay" class="section level2 unnumbered">
<h2>
<strong>Procedure for Performing an Anti-Xa Assay</strong><a class="anchor" aria-label="anchor" href="#procedure-for-performing-an-anti-xa-assay"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Chromogenic Method (Most Common):</strong></p>
<ol style="list-style-type: decimal">
<li>Patient Plasma Preparation: Dilute the patient’s plasma with a specific buffer</li>
<li>Add Antithrombin and Factor Xa: Mix the diluted plasma with antithrombin and a known amount of Factor Xa
<ul>
<li>The anticoagulant drug in the patient’s plasma will inhibit Factor Xa, and this amount of inhibition will be measured</li>
</ul>
</li>
<li>Incubate: Incubate the mixture for a specific period to allow the reaction to proceed</li>
<li>Add Chromogenic Substrate: Add a chromogenic substrate that is specific for Factor Xa
<ul>
<li>Uninhibited Factor Xa will cleave the substrate, releasing a colored product</li>
</ul>
</li>
<li>Measure Absorbance: Measure the absorbance of the solution at a specific wavelength</li>
<li>Calculation: Calculate the anti-Xa activity based on a calibration curve prepared using standards with known concentrations of the anticoagulant drug</li>
</ol>
</li>
<li>
<p><strong>Clotting Method (Less Common):</strong></p>
<ul>
<li>Measures the prothrombin time. Is less accurate and sensitive and thus is becoming obsolete</li>
</ul>
</li>
</ul>
</div>
<div id="interpreting-results-11" class="section level2 unnumbered">
<h2>
<strong>Interpreting Results</strong><a class="anchor" aria-label="anchor" href="#interpreting-results-11"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Anti-Xa Activity Level:</strong>
<ul>
<li>Reported in units of activity (e.g., IU/mL or μg/mL)</li>
<li>Reference Range: Varies depending on the anticoagulant drug and the clinical indication
<ul>
<li>Refer to the laboratory’s established therapeutic range for each drug</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Therapeutic Range:</strong>
<ul>
<li>LMWH: Typical therapeutic ranges for LMWH depend on the dosing schedule (once-daily or twice-daily) and the clinical indication (e.g., treatment of VTE, prophylaxis)</li>
<li>UFH: A target range may be established</li>
<li>DOACs: Some labs offer DOAC specific testing</li>
</ul>
</li>
</ul>
</div>
<div id="factors-affecting-anti-xa-assay-results" class="section level2 unnumbered">
<h2>
<strong>Factors Affecting Anti-Xa Assay Results</strong><a class="anchor" aria-label="anchor" href="#factors-affecting-anti-xa-assay-results"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Pre-Analytical Variables:</strong>
<ul>
<li>Improper Collection Technique: Tissue thromboplastin contamination or hemolysis</li>
<li>Incorrect Blood-to-Anticoagulant Ratio: Underfilling or overfilling the collection tube</li>
<li>Clotted Sample: Invalidates the results</li>
<li>Delayed Testing: Anticoagulant drugs can degrade over time</li>
<li>Improper Storage: Incorrect storage temperatures can affect results</li>
</ul>
</li>
<li>
<strong>Analytical Variables:</strong>
<ul>
<li>Instrument Malfunction: Ensure proper calibration and maintenance of the coagulation analyzer</li>
<li>Reagent Problems: Use fresh, properly stored reagents and follow the manufacturer’s instructions</li>
<li>Interfering Substances: Heparin-induced thrombocytopenia (HIT) antibodies can interfere with the assay</li>
<li>Specific to each test: Reagents, lots numbers, and expirations</li>
</ul>
</li>
<li>
<strong>Patient-Related Variables:</strong>
<ul>
<li>Medications: Other medications that affect coagulation can influence anti-Xa results</li>
<li>Liver Disease: Impairs the synthesis of antithrombin and other coagulation factors</li>
<li>Kidney Disease: Can affect drug clearance and anticoagulant levels</li>
</ul>
</li>
</ul>
</div>
<div id="troubleshooting-erroneous-results-18" class="section level2 unnumbered">
<h2>
<strong>Troubleshooting Erroneous Results</strong><a class="anchor" aria-label="anchor" href="#troubleshooting-erroneous-results-18"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p>If the anti-Xa result is inconsistent with the patient’s clinical presentation or previous results:</p>
<ul>
<li>Check the sample for clots or hemolysis</li>
<li>Repeat the test on a fresh sample</li>
<li>Ensure that the correct blood-to-anticoagulant ratio was used</li>
<li>Verify the instrument and reagent quality control results</li>
<li>Investigate potential interfering substances</li>
<li>Review the patient’s medication list and medical history</li>
<li>Consider the possibility of heparin contamination</li>
</ul>
</li>
</ul>
</div>
<div id="reflex-testing-11" class="section level2 unnumbered">
<h2>
<strong>Reflex Testing</strong><a class="anchor" aria-label="anchor" href="#reflex-testing-11"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>If the anti-Xa result is outside the therapeutic range, consider:
<ul>
<li>Repeat the test to confirm the result</li>
<li>Assess patient adherence to medication regimen</li>
<li>Evaluate for drug interactions</li>
<li>Consider adjusting the anticoagulant dose</li>
<li>If heparin contamination is suspected, perform a heparin neutralization assay</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-105" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-105"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Anti-Xa Assay:</strong> A laboratory test to measure the activity of anticoagulant drugs that inhibit Factor Xa</li>
<li>
<strong>Factor Xa:</strong> A key enzyme in the coagulation cascade</li>
<li>
<strong>Low-Molecular-Weight Heparin (LMWH):</strong> A type of anticoagulant drug (e.g., enoxaparin, dalteparin)</li>
<li>
<strong>Unfractionated Heparin (UFH):</strong> An anticoagulant drug that is monitored using the aPTT or anti-Xa assay</li>
<li>
<strong>Direct Oral Anticoagulants (DOACs):</strong> A class of anticoagulant drugs that includes direct thrombin inhibitors (e.g., dabigatran) and Factor Xa inhibitors (e.g., rivaroxaban, apixaban, edoxaban)</li>
<li>
<strong>Antithrombin:</strong> A natural anticoagulant that inhibits thrombin and other coagulation factors</li>
<li>
<strong>Heparin-Induced Thrombocytopenia (HIT):</strong> A prothrombotic disorder caused by antibodies against heparin-platelet factor 4 complexes</li>
<li>
<strong>Chromogenic Assay:</strong> A type of assay that measures the activity of an enzyme by measuring the production of a colored product</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="pt-20210.html">PT 20210</a></div>
<div class="next"><a href="thrombin-inhibitors.html">Thrombin Inhibitors</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#anti-xa">Anti-Xa</a></li>
<li><a class="nav-link" href="#overview-of-anti-xa-assays">Overview of Anti-Xa Assays</a></li>
<li><a class="nav-link" href="#key-concepts-anticoagulant-mechanisms-of-action">Key Concepts: Anticoagulant Mechanisms of Action</a></li>
<li><a class="nav-link" href="#components-of-the-anti-xa-assay-system">Components of the Anti-Xa Assay System</a></li>
<li><a class="nav-link" href="#procedure-for-performing-an-anti-xa-assay">Procedure for Performing an Anti-Xa Assay</a></li>
<li><a class="nav-link" href="#interpreting-results-11">Interpreting Results</a></li>
<li><a class="nav-link" href="#factors-affecting-anti-xa-assay-results">Factors Affecting Anti-Xa Assay Results</a></li>
<li><a class="nav-link" href="#troubleshooting-erroneous-results-18">Troubleshooting Erroneous Results</a></li>
<li><a class="nav-link" href="#reflex-testing-11">Reflex Testing</a></li>
<li><a class="nav-link" href="#key-terms-105">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/main/05-33-hemostasis-laboratory-hypercoagulability-anti-xa.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/edit/main/05-33-hemostasis-laboratory-hypercoagulability-anti-xa.Rmd">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-23 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
